Mehdi Hadid
Interventional cardiologist
CHRU of Brest -
Latest contributions
Ticagrelor or prasugrel in patients with acute coronary syndromes - ISAR-REACT 5
06 Apr 2020
The objective of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 trial is to test the hypothesis that the ticagrelor strategy is superior to prasugrel strategy in patients with ACS in a composite clinical outcomes.
Reviewer
Reviewer
Cognitive decline before and after incident coronary events
05 Sep 2019
Reviewer
Reviewer
